NCT01259921

Brief Summary

The purpose of this study is to determine whether neurofeedback (NF) training can significantly reduce the symptoms of Posttraumatic Stress Disorder (PTSD) in individuals with significant affect dysregulation and chronic, treatment-resistant PTSD. The primary aims of this study include:

  1. 1.To examine whether NF has the potential to significantly reduce symptoms of PTSD.
  2. 2.To examine whether NF training can specifically target the area of affect regulation.
  3. 3.To examine the mechanism of NF through elucidating the relationship between affect regulation and PTSD symptom change.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2009

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2009

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

December 13, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 14, 2010

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

August 15, 2019

Status Verified

June 1, 2011

Enrollment Period

3 years

First QC Date

December 13, 2010

Last Update Submit

August 13, 2019

Conditions

Keywords

EEG biofeedbackneurofeedbackPTSDAffect RegulationChronic Trauma

Outcome Measures

Primary Outcomes (1)

  • Change in Clinician Administered PTSD Scale Score

    The CAPS is considered the gold standard for the assessment of PTSD (National Center for PTSD Research). It is a clinician administered 30-item interview that corresponds to DSM-IV criteria for PTSD. Each item of the CAPS has two parts, frequency and intensity, which are both scored on a 5-point scale from 0 to 4. A general cut-off rule of frequency greater than or equal to 1 and intensity greater than or equal to 2 for a symptom to count towards diagnosis will be employed in assigning PTSD diagnosis.

    Participants are assessed at baseline (prior to beginning training), post-treatment (corresponding to 20 weeks), and at follow-up (1 year post treatment)

Secondary Outcomes (2)

  • Change in Davidson Trauma Scale Score

    Participants are assessed at baseline (prior to beginning training), every 4 weeks (corresponding to 8 sessions of training), post-treatment (corresponding to 20 weeks), and at follow-up (1 year post treatment)

  • Change in Inventory of Altered Self-Capacities Score

    Participants are assessed at baseline (prior to beginning training), every 4 weeks (corresponding to 8 sessions of training), post-treatment (corresponding to 20 weeks), and at follow-up (1 year post treatment)

Study Arms (2)

Neurofeedback T4-P4

EXPERIMENTAL

40 sessions of SMR neurofeedback training using T4-P4 placement administered twice weekly

Behavioral: neurofeedback

Neurofeedback T3-T4

ACTIVE COMPARATOR

40 sessions of SMR neurofeedback using T3-T4 placement training administered twice weekly

Behavioral: neurofeedback

Interventions

neurofeedbackBEHAVIORAL

Operant conditioning of the EEG provided by computer reinforcement.

Also known as: EEG Spectrum International, Thought Technologies, ProComp 2
Neurofeedback T3-T4Neurofeedback T4-P4

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • CAPS score of 60 or over
  • t-score of 70 or over on the affect dysregulation subscale of the IASC; AND
  • Treatment-unresponsiveness as defined by having had at least 3 years of prior treatment focused on dealing with the consequences of the index trauma, or having been in treatment with more than three providers during the preceding decade

You may not qualify if:

  • Serious non-stable medical illness
  • GAF \< 40
  • Bipolar disorder, obsessive-compulsive disorder (OCD), schizophrenia, and other psychotic disorder, or documented organic impairment
  • Active suicidal risk, self-injury or physical aggression toward others within the past year
  • Substance dependence or abuse in the past 6 months, as defined by DSM IV criteria
  • Individuals taking a benzodiazepine more than twice per week (non-response seen in pilot work) AND
  • Any other condition that might interfere with the person's capacity to give informed consent, or to adhere to the study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the Trauma Center at JRI

Brookline, Massachusetts, 02446, United States

Location

Related Publications (1)

  • Gapen M, van der Kolk BA, Hamlin E, Hirshberg L, Suvak M, Spinazzola J. A Pilot Study of Neurofeedback for Chronic PTSD. Appl Psychophysiol Biofeedback. 2016 Sep;41(3):251-61. doi: 10.1007/s10484-015-9326-5.

    PMID: 26782083BACKGROUND

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Neurofeedback

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Biofeedback, PsychologyMind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesFeedback, Psychological

Study Officials

  • Bessel van der Kolk, M.D.

    Justice Resource Institute

    PRINCIPAL INVESTIGATOR
  • Mark Gapen, Ph.D.

    Justice Resource Institute

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: EEG Biofeedback versus wait list control condition.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2010

First Posted

December 14, 2010

Study Start

December 1, 2009

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

August 15, 2019

Record last verified: 2011-06

Locations